Effectiveness of Pharmaceutical Lifecycle Management Tactics
This survey-based benchmarking exchange was designed to understand how companies can extend and optimize the value of pharmaceutical products as they enter the late mature phase of the product life cycle. This study identifies those activities that have proven to be successful life cycle management techniques for the late mature phase. These tactics can help extend product life, find new markets and continue product growth.
Pharmaceutical, medical device and biotech companies can benefit from this 54-slide presentation on the most commonly utilized life cycle management strategies.
Key topics covered in this document:
- Tactic Use - Frequency
- Tactic Use - Success Rate
- Months Gained
- Incremental Revenues Gained
- Considerations Before Use
- Time Required for Success
- Funds Required for Success
- Challenges
- Key Success Factors
- Response Matrix
Select findings include:
- Successful lifecycle management tactics gained companies as much as 10 years of additional product life.
- The average number of months gained by respondents using LCM strategies ranged from two to 78 months.
- The top five most used tactics are also the top five most frequently successful tactics. Those are: new formulations, new indications, publication strategy, thought leaders and line extensions.
Sales and Marketing > New Product Development and Launch d
Industries Profiled:
Pharmaceutical; Chemical; Biotech; Health Care; Medical Device; Consumer Products; Diagnostic
Companies Profiled:
Abbott Laboratories; Solvay America; Sanofi-Synthelabo Inc.; Pfizer; Ortho Biotech; Organon; Novartis; Eli Lilly and Company; IVAX; Baxter Healthcare; Bayer
Related Research:
R&D Quality Assurance Excellence Library
 |
A must-have for all pharmaceutical, biotech and medical device manufacturing executives, this Best Practices' R&D Quality Assurance bundle tells you everything you need to know about quality... (ID OPS-95)
Companies Profiled: aaiPharma, Sanofi-aventis, Abbott, Abbott Laboratories, more ...
Price: $21100.00 Free Excerpt Available
| |
Best Practices in Global Pharmaceutical Launches
 |
Discover how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities... (ID SM-120)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, Wyeth, more ...
Price: $7000.00 Free Excerpt Available
| |
|